Linagliptin Impurity K

Linagliptin Impurity K is a structurally related synthetic byproduct arising from the amidation step in linagliptin synthesis. It retains the core pyrazine-tetrahydrofuran scaffold but features a truncated side chain with an additional methylene group at the C-terminus, replacing the parent drug's sulfonamide moiety. This impurity exhibits a distinct N-aryl substitution pattern, lacking the meta-chlorophenyl ring of linagliptin, and incorporates a secondary amine linkage at the propylamide terminus. Its unique substitution profile confers altered HPLC retention characteristics, enabling its use as a reference standard for quantifying process-related impurities in linagliptin active pharmaceutical ingredient (API) batches.